Dexamethasone on Fetal and Uteroplacental Doppler

• Register: ClinicalTrials.gov
• Last refreshed on: 1 February 2016
• Main ID: NCT02662790
• Date of registration: 15/01/2016
• Prospective Registration: No
• Primary sponsor: Assiut University
• Public title: Dexamethasone on Fetal and Uteroplacental Doppler
• Scientific title: Effects of Antenatal Dexamethasone Administration on Fetal and Uteroplacental Doppler Waveforms in Women at Risk for Preterm Birth
• Date of first enrolment: February 2014
• Target sample size: 50
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02662790
• Study type: Interventional
• Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: Phase 2

Countries of recruitment

Egypt

Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients at risk of preterm labor to be included were those with preterm uterine
contractions, placenta previa, and mild preeclampsia

Exclusion Criteria:

- Patients who were actively in labor, presented with premature rupture of membranes,
intrauterine growth restriction (IUGR), those who had received corticosteroids in
their pregnancies and/or fetuses with suspected structural abnormalities



Age minimum: N/A
Age maximum: N/A
Gender: Female

Health Condition(s) or Problem(s) studied

Preterm Birth

Intervention(s)

Other: Doppler

Primary Outcome(s)

mean of Doppler Resistance index (RI) [Time Frame: 24 hours]

Secondary Outcome(s)

mean of Doppler Pulsatility index (PI) [Time Frame: 24 hours]

Secondary ID(s)

DEXA

Source(s) of Monetary Support

Please refer to primary and secondary sponsors